“Attention Shareholders: Don’t Miss Your Chance to Lead the Way with Levi and Korsinsky – Important Deadline Reminder!”
Seeking Recovery for Regeneron Pharmaceuticals, Inc. Investment Loss Introduction New York, NY / ACCESS Newswire / January 26, 2025 – If you are an investor who has suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment, you may be eligible for a potential recovery under the federal securities laws. It is important to understand…